University of Miami Sylvester Comprehensive Cancer Center

 

CLL Therapy in 2019
13:16

University of Miami's 2nd Biennial Miami Leukemia Symposium

Advances in the CLL Frontline Therapy: BTK Inhibitors vs. Chemoimmunotherapy, Venetoclax vs. Chemoimmunotherapy

FEATURING Jennifer Woyach
  • 147 views
  • May 14, 2020
  • 1
07:09

University of Miami's 2nd Biennial Miami Leukemia Symposium

The Big Question in CLL Frontline Therapy: How to Choose Between Ibrutinib, Acalabrutinib & Venetoclax?

FEATURING Jennifer Woyach
  • 272 views
  • May 14, 2020
24:51

University of Miami's 2nd Biennial Miami Leukemia Symposium

2020 Update on Combination Therapies in R/R CLL: Venetoclax +R, Venetoclax + BTKi, Venetoclax + PI3Ki & BTKi + PI3Ki

FEATURING Matthew Davids
  • 47 views
  • May 14, 2020